MDLN · CUSIP 58507V107
MEDLINE INC
Reported by 4 of 79 curated managers in Q2 2026, in the holdings snapshot last exported 2026-10-26.
- Managers holding
- 4
- Average portfolio weight
- 2.8%
- Combined reported value
- $1.6B
- Research group
- 79
4 of the 79 superinvestors Shameless Cloning tracks reported MEDLINE INC (MDLN) in their Q2 2026 13F filings, worth $1.6B combined, at an average 2.8% of their portfolios. The largest positions by portfolio weight belong to Stephen Mandel (5.1%), John Armitage (4.7%), Henry Ellenbogen (1.0%).
Reporting managers
This is a historical 13F snapshot, not a live shareholder register. The count covers all matched managers; dashboard rankings use only those with at least 95% coverage. Reported value is measured at filing quarter-end, not at today's price.
| Manager / SEC filer | % of portfolio | Reported value |
|---|---|---|
| Stephen MandelLONE PINE CAPITAL LLC | 5.1% | $827.0M |
| John ArmitageEgerton Capital (UK) LLP | 4.7% | $460.9M |
| Henry EllenbogenDurable Capital Partners LP | 1.0% | $103.6M |
| Viking Global InvestorsVIKING GLOBAL INVESTORS LP | 0.5% | $190.9M |